Sage Therapeutics begins dosing in Phase I trial of SAGE-718

US-based biopharmaceutical firm Sage Therapeutics has begun dosing healthy volunteers in its Phase I clinical trial of SAGE-718.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news